Proton-Pump Inhibitors: Do Children Break a Leg by Using Them?

Area of Science:

• Pediatric pharmacology and gastroenterology.
• Bone health and fracture risk assessment in children.

Background:

• Growing concerns exist regarding potential bone fracture risks associated with proton-pump inhibitor (PPI) use in pediatric patients.
• Recent publications have highlighted this issue, creating uncertainty for healthcare providers, patients, and parents.

Purpose of the Study:

• To provide an updated evidence-based overview of the association between PPI treatment and bone fracture risk in children.
• To address inconsistencies in current risk claims and reduce unwarranted anxiety.
• To encourage well-designed research to definitively evaluate this potential adverse effect.

Main Methods:

• Comprehensive literature review of existing studies and publications.
• Analysis of current evidence regarding proton-pump inhibitor (PPI) use and pediatric bone fractures.
• Synthesis of findings to identify areas of consensus and discrepancy.

Main Results:

• Current evidence on the link between PPIs and pediatric bone fractures lacks consistency.
• The available data does not provide a definitive conclusion on the increased risk.
• Further well-planned studies are needed to clarify the association.

Conclusions:

• The association between proton-pump inhibitors (PPIs) and bone fracture risk in children remains unclear.
• An updated understanding of the evidence is crucial for informed clinical decision-making.
• Prudent prescribing practices and continued research are recommended.